QualityStocksNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Prices $15 Million Public Offering in Connection With Nasdaq Uplisting
This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) announced the pricing of its underwritten public offering in connection with its uplisting to the Nasdaq Capital Market, offering 2.4 million common shares at US$6.25 per share for expected gross proceeds of approximately US$15 million, excluding any exercise of the underwriter’s option to purchase up to an additional 360,000 shares. Joseph Gunnar & Co. LLC is acting as sole book-running manager for the offering, with trading on Nasdaq expected to begin May 20, 2026, under the…
